{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:05:35Z","timestamp":1761059135719},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00296-010-1677-x","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T10:27:36Z","timestamp":1291112856000},"page":"431-434","source":"Crossref","is-referenced-by-count":3,"title":["Investigation of effects of two-different treatment modalities on nerve conduction in patients with ankylosing spondylitis"],"prefix":"10.1007","volume":"32","author":[{"given":"Erhan","family":"Capkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Karkucak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muammer Muslim","family":"Kose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vildan Altunayo\u011flu","family":"\u00c7akmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul Kucukali","family":"Turkyilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Tosun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,1]]},"reference":[{"key":"1677_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000289195","volume":"11","author":"M Apostolaki","year":"2010","unstructured":"Apostolaki M, Armaka M, Victoratos P et al (2010) Cellular mechanisms of TNF function in models of inflammation and autoimmunity. Curr Dir Autoimmun 11:1\u201326","journal-title":"Curr Dir Autoimmun"},{"key":"1677_CR2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","volume":"9","author":"C Manuel Ramos","year":"2010","unstructured":"Manuel Ramos C, Roberto-Perez A, Candido Diaz L et al (2010) Autoimmune diseases induced by biological agents; A double-edged sword? Autoimmun Rev 9:188\u2013193","journal-title":"Autoimmun Rev"},{"key":"1677_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","volume":"37","author":"JB Stubgen","year":"2008","unstructured":"Stubgen JB (2008) Tumor Necrosis Factor-\u03b1 antagonists and neuropathy. Muscle Nerve 37:281\u2013292","journal-title":"Muscle Nerve"},{"key":"1677_CR4","first-page":"14","volume":"6","author":"C Kokona","year":"2006","unstructured":"Kokona C, Athanasia M (2006) Anti-TNF-a Antibody Therapies in Autoimmune Diseases. Curr Top Med Chem 6:14\u20131707","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"1677_CR5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/09546630802441234","volume":"20","author":"JM Ko","year":"2009","unstructured":"Ko JM, Gottlieb AB, Kerbleski JF (2009) Induction and exacerbation of psoriasis with TNF-\u03b1 blockade therapy: a review and analysis of 127 cases. J Dermatolog Treat 20(2):100\u2013108","journal-title":"J Dermatolog Treat"},{"key":"1677_CR6","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","volume":"44","author":"N Mohan","year":"2001","unstructured":"Mohan N, Edwards ET, Cupps TR et al (2001) Demyelination occurring during anti-tumornecrosis factor\u2014therapy for inflammatory arthritides. Arthritis Rheum 44:2862\u20132869","journal-title":"Arthritis Rheum"},{"key":"1677_CR7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zeron P, Munoz S et al (2007) Autoimmune diseases induced by TNF targeted therapies: analysis of 233 cases. Medicine 86:242\u2013251","journal-title":"Medicine"},{"key":"1677_CR8","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6","volume":"44","author":"WH Robinson","year":"2001","unstructured":"Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor\u2014antagonism. Arthritis Rheum 44:1977\u20131983","journal-title":"Arthritis Rheum"},{"key":"1677_CR9","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1212\/01.WNL.0000142974.81103.95","volume":"63","author":"OC Singer","year":"2004","unstructured":"Singer OC, Otto B, H Steinmetz et al (2004) Acute neuropathy with multiple conduction blocks after TNF-\u03b1 monoclonal antibody therapy. Neurology 63:1754","journal-title":"Neurology"},{"key":"1677_CR10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410330602","volume":"33","author":"H-P Hartung","year":"1993","unstructured":"Hartung H-P (1993) Immune-mediated demyelination. Ann Neurol 33:563\u2013567","journal-title":"Ann Neurol"},{"key":"1677_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","volume":"84","author":"J Zhu","year":"1998","unstructured":"Zhu J, Mix E, Link H (1998) Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain\u2013Barre\u2032 syndrome. J Neuroimmunol 84:40\u201352","journal-title":"J Neuroimmunol"},{"key":"1677_CR12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ana.410420112","volume":"42","author":"MK Sharief","year":"1997","unstructured":"Sharief MK, Ingram DA, Swash M (1997) Circulating tumor necrosis factor-\u03b1 correlates with electrodiagnostic abnormalities in Guillain\u2013Barre\u2032 syndrome. Ann Neurol 42:68\u201373","journal-title":"Ann Neurol"},{"key":"1677_CR13","first-page":"10","volume":"40","author":"HP Hartung","year":"1992","unstructured":"Hartung HP, Jung S, Stoll G et al (1992) The role of inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 40:10\u2013197","journal-title":"J Neuroimmunol"},{"key":"1677_CR14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0923-2494(92)80040-R","volume":"143","author":"G Said","year":"1992","unstructured":"Said G, Hontebeyrie-Joskowicz M (1992) Nerve lesions induced by macrophage activation. Res Immunol 143:589\u2013599","journal-title":"Res Immunol"},{"key":"1677_CR15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s10067-007-0657-3","volume":"26","author":"PJ Kotyla","year":"2007","unstructured":"Kotyla PJ, Sliwinska-Kotyla B, Kucharz EJ (2007) Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis. Clin Rheumatol 26:1595\u20131596","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1677_CR16","first-page":"243","volume":"102","author":"OH G\u00fcnd\u00fcz","year":"2010","unstructured":"G\u00fcnd\u00fcz OH, Kiralp MZ, Oz\u00e7akar L et al (2010) Nerve conduction studies in patients with ankylosing spondylitis. J Natl Med Assoc 102(3):243\u2013246","journal-title":"J Natl Med Assoc"},{"issue":"4","key":"1677_CR17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","volume":"66","author":"P Lozeron","year":"2009","unstructured":"Lozeron P, Denier C, Lacroix C et al (2009) Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy. Arch Neurol 66(4):490\u2013497","journal-title":"Arch Neurol"},{"key":"1677_CR18","first-page":"81","volume":"31","author":"P Richette","year":"2004","unstructured":"Richette P, Dieude P, Damiano J et al (2004) Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. J Rheumatol 31:81\u20132079","journal-title":"J Rheumatol"},{"key":"1677_CR19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/14787210.1.4.597","volume":"1","author":"RS Tsang","year":"2003","unstructured":"Tsang RS, Valdivieso-Garcia A (2003) Pathogenesis of Guillain\u2013Barre\u2032 syndrome. Expert Rev Anti Infect Ther 1:597\u2013608","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1677_CR20","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/01.WNL.0000158681.29117.8B","volume":"64","author":"C Richez","year":"2005","unstructured":"Richez C, Blanco P, Lagueny A et al (2005) Neuropathy resembling CIDP in patients receiving tumornecrosis factor-\u03b1 blockers. Neurology 64:1468\u20131470","journal-title":"Neurology"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1677-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-010-1677-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1677-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:18:47Z","timestamp":1559042327000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1677-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1677"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1677-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,1]]}}}